DULAVIGO Trademark Information

Trademark by Bristol-Myers Squibb Company

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, imm...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: DULAVIGO
Status/Status Date:
FIFTH EXTENSION - GRANTED
1/11/2021
Serial Number: 87525914
Filing Date: 7/12/2017
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 5/22/2018
Last Applicant/Owner:
Bristol-Myers Squibb Company
New York, NY 10016
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT., MAILSTOP B22-02
P.O. BOX 4000
PRINCETON NJ 08648-4000
Current Status:
FIFTH EXTENSION - GRANTED
1/11/2021
Correspondent Search:
MARILYN F. KELLY is a correspondent of DULAVIGO trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on